Growth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells.
Boostanfar
Robert
R
Amezcua
Charles A
CA
Tourgeman
David E
DE
Roy
Subir
S
Felix
Juan C
JC
Stanczyk
Frank Z
FZ
D000230:Adenocarcinoma / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D016889:Endometrial Neoplasms / Q000473:pathology*; D004958:Estradiol / Q000494:pharmacology; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D020849:Raloxifene Hydrochloride / Q000494:pharmacology*; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride; D011374:Progesterone; D004958:Estradiol; D017258:Medroxyprogesterone Acetate